4.5 Article

A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: results from the SPIRIT randomized trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Nutrition & Dietetics

Higher Lipopolysaccharide Binding Protein and Chemerin Concentrations Were Associated with Metabolic Syndrome Features in Pediatric Subjects with Abdominal Obesity during a Lifestyle Intervention

Amelia Marti et al.

Summary: The study found that plasma levels of LBP and chemerin decreased significantly in children and adolescents with abdominal obesity after a lifestyle intervention, and were associated with MetS risk factors. This suggests that LBP and chemerin plasma levels could serve as biomarkers for assessing the progression of cardiovascular risk in pediatric populations.

NUTRIENTS (2021)

Article Endocrinology & Metabolism

Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial

Noel T. Mueller et al.

Summary: The study found that metformin treatment significantly altered gut microbiota composition at both 6 months and 12 months, while behavioral weight loss did not have the same effect. Additionally, both metformin and behavioral weight loss changed circulating SCFAs at 6 months, with an increase in acetate correlating with lower fasting insulin levels. Further research is needed to explore whether the gut microbiome mediates or modifies the health effects of metformin.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial

Hsin-Chieh Yeh et al.

Summary: This study found that metformin may have a short-term effect on reducing IGF-1 levels in cancer survivors with obesity, but this effect diminishes over time.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Multidisciplinary Sciences

Regulation of adipose tissue inflammation by interleukin 6

Myoung Sook Han et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Endocrinology & Metabolism

Metformin: Mechanisms in Human Obesity and Weight Loss

Armen Yerevanian et al.

CURRENT OBESITY REPORTS (2019)

Article Nutrition & Dietetics

Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction

Antje Damms-Machado et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)

Article Multidisciplinary Sciences

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

Kristoffer Forslund et al.

NATURE (2015)

Article Endocrinology & Metabolism

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

J. M. Moreno-Navarrete et al.

INTERNATIONAL JOURNAL OF OBESITY (2012)

Review Biochemistry & Molecular Biology

The pro- and anti-inflammatory properties of the cytokine interleukin-6

Juergen Scheller et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)

Article Medicine, General & Internal

Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice

Lawrence J. Appel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Association of upopolysaccharide-binding protein and coronary artery disease in men

Philipp M. Lepper et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Endocrinology & Metabolism

Metabolic endotoxemia initiates obesity and insulin resistance

Patrice D. Cani et al.

DIABETES (2007)

Article Endocrinology & Metabolism

Body size and shape changes and the risk of diabetes in the diabetes prevention program

Wilfred Y. Fujimoto et al.

DIABETES (2007)

Review Oncology

The pathobiology of mucositis

ST Sonis

NATURE REVIEWS CANCER (2004)

Review Microbiology

Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock

ES Van Amersfoort et al.

CLINICAL MICROBIOLOGY REVIEWS (2003)